COMBIVIR ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
265	脂肪萎縮症	2

265. 脂肪萎縮症

臨床試験数 : 112 / 薬物数 : 155 - (DrugBank : 55) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 97

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2005-004021-26-GB (EUCTR)	06/10/2005	05/09/2005	Longitudinal relationship between lipodystrophy and adipocyte mitochondria DNA in HIV Patients: comp ...	Longitudinal relationship between lipodystrophy and adipocyte mitochondria DNA in HIV Patients: comp ...	HIV	Trade Name: SUSTIVA Product Name: Efavirenz Trade Name: COMBIVIR Product Name: AZT/3TC Trade Name: TRUVA ...	University Hospital Birmingham	NULL	Not Recruiting			Female: yes Male: yes	60	Human pharmacology (Phase 1): Therapeutic exploratory (Phase 2): Therapeutic confirmatory - (Phase 3 ...	United Kingdom
2	NCT00192621 (ClinicalTrials.gov)	November 2004	12/9/2005	Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kalet ...	A 3 Arm, Prospective Study to Compare the Effect of 6 Weeks Exposure to the Combination of Lopinavir ...	HIV Infections;Dyslipidemias;Glucose Metabolism Disorders;Metabolic Diseases;Lipodystrophy;Cardiovas ...	Drug: Combivir (zidovudine [AZT] / lamivudine [3TC]);Drug: Kaletra (lopinavir [LPVr])	Kirby Institute	St Vincent's Hospital, Sydney;National Heart, Lung, and Blood Institute (NHLBI);Garvan Institute of ...	Completed	18 Years	N/A	Both	50	Phase 4	Australia

First Previous1Next Last